Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
March 28, 2024 07:30 ET
|
Optimi Health Corp.
Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
March 25, 2024 07:48 ET
|
MetasTx LLC
Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
March 21, 2024 07:58 ET
|
CAMP4 Therapeutics
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle D
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
March 14, 2024 05:00 ET
|
S. M. Discovery Group (SMDG)
SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards
March 13, 2024 09:30 ET
|
Rentschler Biopharma SE
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
Taylor Esser Talks Career Change From Finance to Business Owner After Buying 40-Year Business The Ink Spot & Opening Minuteman Press Franchise in Quincy, MA
March 06, 2024 11:30 ET
|
Minuteman Press International
Taylor Esser talks career transition from corporate finance to Minuteman Press franchise owner in Quincy, MA.
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
February 29, 2024 09:54 ET
|
PRISM MarketView
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
Digital Therapeutics Market Size to Reach US$24.5 Billion by 2030, Forecasts Fairfield Market Research in a New Report
February 27, 2024 07:32 ET
|
Fairfield Consultancy Services OPC Pvt Ltd
London, Feb. 27, 2024 (GLOBE NEWSWIRE) -- As indicated by a newly published report by Fairfield Market Research, the global market for digital therapeutics is poised to witness staggering growth,...
Global Ophthalmic Drugs Market Size is Estimated to Reach USD 62.55 billion by 2030, Growing at a CAGR of 7.4%: Straits Research
February 21, 2024 10:20 ET
|
Straits Research
New York, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Anti-infectives in a product designed specifically to be injected into or applied to the eye or eyes are known as ophthalmic...
Pneumonia Therapeutics Market Forecasted to Grow at a CAGR of 7.3% by 2031, Reaching a Total Worth of USD 5.7 billion | Transparency Market Research, Inc.
February 19, 2024 05:05 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The pneumonia therapeutics market was valued at US$ 3.0 billion in 2022. A CAGR of 7.3% is...